Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology
<!-- Name:DistributionId Value:8800557 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4500 -->…
Browsing Tag
Comera Life Sciences
Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One…
WOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and…
Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business Solutions
WOBURN, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient…
Comera Life Sciences Provides Business Highlights and Reports Financial Results for the Second…
WOBURN, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and…
Comera Life Sciences Announces Favorable Preclinical Topline Safety Results of Lead SQore Excipient
WOBURN, Mass., July 13, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and…